Recruiting
Phase 3

Low Dose Tamoxifen

Sponsor:

Alliance for Clinical Trials in Oncology

Code:

NCT06671912

Conditions

Anatomic Stage 0 Breast Cancer AJCC v8

Anatomic Stage 1 Breast Cancer AJCC v8

Anatomic Stage IIA Breast Cancer AJCC v8

Estrogen Receptor-Positive Breast Carcinoma

HER2-Negative Breast Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Anastrozole

Letrozole

Exemestane

Tamoxifen

Mammogram

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-16. This information was provided to ClinicalTrials.gov by Alliance for Clinical Trials in Oncology on 2025-04-02.